REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $620 | -77.8% | 6,819 | -90.7% | 0.00% | -71.4% |
| Q4 2022 | $2,787 | -99.7% | 73,374 | +97.1% | 0.01% | +133.3% |
| Q3 2022 | $935,000 | -76.3% | 37,218 | -4.9% | 0.00% | -62.5% |
| Q3 2021 | $3,937,000 | -29.1% | 39,135 | -0.2% | 0.01% | -27.3% |
| Q2 2021 | $5,549,000 | +8.2% | 39,210 | -23.7% | 0.01% | 0.0% |
| Q1 2021 | $5,127,000 | -22.6% | 51,421 | -4.1% | 0.01% | -26.7% |
| Q4 2020 | $6,627,000 | +393.4% | 53,613 | +288.8% | 0.02% | +275.0% |
| Q3 2020 | $1,343,000 | -41.1% | 13,789 | -5.6% | 0.00% | -42.9% |
| Q2 2020 | $2,279,000 | +8.1% | 14,607 | 0.0% | 0.01% | -12.5% |
| Q1 2020 | $2,108,000 | – | 14,607 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |